Cargando…

The Intrahepatic Expression and Distribution of BTLA and its Ligand HVEM in patients with HBV-related acute-on-chronic liver failure

OBJECTIVE: It has been demonstrated that signals from the inhibitory receptor B and T lymphocyte attenuator (BTLA) are involved in regulating the pathogenesis of infectious diseases. However, the expression and anatomical distribution of BTLA and its ligand, the herpes virus entry mediator (HVEM), h...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Huan, Cao, Dayan, Guo, Guoning, Ruan, Zhihua, Wu, Yuzhang, Chen, Yongwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488509/
https://www.ncbi.nlm.nih.gov/pubmed/23067542
http://dx.doi.org/10.1186/1746-1596-7-142
_version_ 1782248626304581632
author Xu, Huan
Cao, Dayan
Guo, Guoning
Ruan, Zhihua
Wu, Yuzhang
Chen, Yongwen
author_facet Xu, Huan
Cao, Dayan
Guo, Guoning
Ruan, Zhihua
Wu, Yuzhang
Chen, Yongwen
author_sort Xu, Huan
collection PubMed
description OBJECTIVE: It has been demonstrated that signals from the inhibitory receptor B and T lymphocyte attenuator (BTLA) are involved in regulating the pathogenesis of infectious diseases. However, the expression and anatomical distribution of BTLA and its ligand, the herpes virus entry mediator (HVEM), have not yet been determined in cases of HBV-related acute-on-chronic liver failure (HBV-ACLF) patients. METHODS: In this study, the expression of BTLA and HVEM in liver tissues from HBV-ACLF, chronic hepatitis B (CHB) patients and healthy individuals was analyzed by immunohistochemistry. RESULTS: The results of this analysis demonstrated that both molecules were observed in the HBV-ACLF samples and that their expression was chiefly in the infiltrating inflammatory cells and the damaged bile ducts. However, they were absent in liver sections from CHB patients and healthy controls. Immunofluorescence double-staining indicated that BTLA was found on CK-18(+) epithelial cells, CD31(+) endothelial cells, CD68(+) macrophages, CD56(+) NK cells, CD16(+) monocytes, CD3(+) , CD8(+) T cells, and Foxp3(+) regulatory T cells (Treg). By contrast, HVEM expression was restricted to CK18(+) epithelial cells and CD68(+) macrophages. Moreover, the expression of several members of the B7 superfamily, including PD-L1, PD-L2, B7-H3 and B7-H4, was also detected in these liver tissues, and these proteins were co-expressed with HVEM. Interestingly, the expression of fibrinogen-like protein 2 (FGL2), a virus-induced procoagulant molecule, was also found in liver sections from HBV-ACLF, this molecule also co-expresses with BTLA and HVEM. CONCLUSIONS: These results suggest that BTLA-HVEM signaling is likely to affect the pathogenesis of HBV-ACLF, a clear understanding of the functional roles of these proteins should further elucidate the disease process. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/8080806838149123
format Online
Article
Text
id pubmed-3488509
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34885092012-11-05 The Intrahepatic Expression and Distribution of BTLA and its Ligand HVEM in patients with HBV-related acute-on-chronic liver failure Xu, Huan Cao, Dayan Guo, Guoning Ruan, Zhihua Wu, Yuzhang Chen, Yongwen Diagn Pathol Research OBJECTIVE: It has been demonstrated that signals from the inhibitory receptor B and T lymphocyte attenuator (BTLA) are involved in regulating the pathogenesis of infectious diseases. However, the expression and anatomical distribution of BTLA and its ligand, the herpes virus entry mediator (HVEM), have not yet been determined in cases of HBV-related acute-on-chronic liver failure (HBV-ACLF) patients. METHODS: In this study, the expression of BTLA and HVEM in liver tissues from HBV-ACLF, chronic hepatitis B (CHB) patients and healthy individuals was analyzed by immunohistochemistry. RESULTS: The results of this analysis demonstrated that both molecules were observed in the HBV-ACLF samples and that their expression was chiefly in the infiltrating inflammatory cells and the damaged bile ducts. However, they were absent in liver sections from CHB patients and healthy controls. Immunofluorescence double-staining indicated that BTLA was found on CK-18(+) epithelial cells, CD31(+) endothelial cells, CD68(+) macrophages, CD56(+) NK cells, CD16(+) monocytes, CD3(+) , CD8(+) T cells, and Foxp3(+) regulatory T cells (Treg). By contrast, HVEM expression was restricted to CK18(+) epithelial cells and CD68(+) macrophages. Moreover, the expression of several members of the B7 superfamily, including PD-L1, PD-L2, B7-H3 and B7-H4, was also detected in these liver tissues, and these proteins were co-expressed with HVEM. Interestingly, the expression of fibrinogen-like protein 2 (FGL2), a virus-induced procoagulant molecule, was also found in liver sections from HBV-ACLF, this molecule also co-expresses with BTLA and HVEM. CONCLUSIONS: These results suggest that BTLA-HVEM signaling is likely to affect the pathogenesis of HBV-ACLF, a clear understanding of the functional roles of these proteins should further elucidate the disease process. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/8080806838149123 BioMed Central 2012-10-15 /pmc/articles/PMC3488509/ /pubmed/23067542 http://dx.doi.org/10.1186/1746-1596-7-142 Text en Copyright ©2012 Xu et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Xu, Huan
Cao, Dayan
Guo, Guoning
Ruan, Zhihua
Wu, Yuzhang
Chen, Yongwen
The Intrahepatic Expression and Distribution of BTLA and its Ligand HVEM in patients with HBV-related acute-on-chronic liver failure
title The Intrahepatic Expression and Distribution of BTLA and its Ligand HVEM in patients with HBV-related acute-on-chronic liver failure
title_full The Intrahepatic Expression and Distribution of BTLA and its Ligand HVEM in patients with HBV-related acute-on-chronic liver failure
title_fullStr The Intrahepatic Expression and Distribution of BTLA and its Ligand HVEM in patients with HBV-related acute-on-chronic liver failure
title_full_unstemmed The Intrahepatic Expression and Distribution of BTLA and its Ligand HVEM in patients with HBV-related acute-on-chronic liver failure
title_short The Intrahepatic Expression and Distribution of BTLA and its Ligand HVEM in patients with HBV-related acute-on-chronic liver failure
title_sort intrahepatic expression and distribution of btla and its ligand hvem in patients with hbv-related acute-on-chronic liver failure
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488509/
https://www.ncbi.nlm.nih.gov/pubmed/23067542
http://dx.doi.org/10.1186/1746-1596-7-142
work_keys_str_mv AT xuhuan theintrahepaticexpressionanddistributionofbtlaanditsligandhveminpatientswithhbvrelatedacuteonchronicliverfailure
AT caodayan theintrahepaticexpressionanddistributionofbtlaanditsligandhveminpatientswithhbvrelatedacuteonchronicliverfailure
AT guoguoning theintrahepaticexpressionanddistributionofbtlaanditsligandhveminpatientswithhbvrelatedacuteonchronicliverfailure
AT ruanzhihua theintrahepaticexpressionanddistributionofbtlaanditsligandhveminpatientswithhbvrelatedacuteonchronicliverfailure
AT wuyuzhang theintrahepaticexpressionanddistributionofbtlaanditsligandhveminpatientswithhbvrelatedacuteonchronicliverfailure
AT chenyongwen theintrahepaticexpressionanddistributionofbtlaanditsligandhveminpatientswithhbvrelatedacuteonchronicliverfailure
AT xuhuan intrahepaticexpressionanddistributionofbtlaanditsligandhveminpatientswithhbvrelatedacuteonchronicliverfailure
AT caodayan intrahepaticexpressionanddistributionofbtlaanditsligandhveminpatientswithhbvrelatedacuteonchronicliverfailure
AT guoguoning intrahepaticexpressionanddistributionofbtlaanditsligandhveminpatientswithhbvrelatedacuteonchronicliverfailure
AT ruanzhihua intrahepaticexpressionanddistributionofbtlaanditsligandhveminpatientswithhbvrelatedacuteonchronicliverfailure
AT wuyuzhang intrahepaticexpressionanddistributionofbtlaanditsligandhveminpatientswithhbvrelatedacuteonchronicliverfailure
AT chenyongwen intrahepaticexpressionanddistributionofbtlaanditsligandhveminpatientswithhbvrelatedacuteonchronicliverfailure